Sonova Holding (OTCMKTS:SONVY) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Wednesday.
According to Zacks, “Sonova Holding AG is a manufacturer of hearing care solutions. The company’s operating business brands consists of Phonak, Unitron, Advanced Bionics and AudioNova. Its product portfolio consists of hearing instruments and cochlear implants to wireless communication solutions. Sonova Holding AG is headquartered in Stäfa, Switzerland. “
Shares of Sonova Holding (SONVY) opened at $33.51 on Wednesday. Sonova Holding has a 52-week low of $22.70 and a 52-week high of $36.19. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.87 and a quick ratio of 1.45.
Sonova Holding Company Profile
Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand name; and professional audiological services under the Connect Hearing brand name.
Receive News & Ratings for Sonova Holding Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova Holding and related companies with MarketBeat.com's FREE daily email newsletter.